[go: up one dir, main page]

AR078160A1 - Derivados de aminopiridina sustituidos, a su uso en terapia, y a composiciones farmaceuticas que los contiene - Google Patents

Derivados de aminopiridina sustituidos, a su uso en terapia, y a composiciones farmaceuticas que los contiene

Info

Publication number
AR078160A1
AR078160A1 ARP100103258A ARP100103258A AR078160A1 AR 078160 A1 AR078160 A1 AR 078160A1 AR P100103258 A ARP100103258 A AR P100103258A AR P100103258 A ARP100103258 A AR P100103258A AR 078160 A1 AR078160 A1 AR 078160A1
Authority
AR
Argentina
Prior art keywords
compound
heterocyclic ring
derivatives
aminopiridine
therapy
Prior art date
Application number
ARP100103258A
Other languages
English (en)
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of AR078160A1 publication Critical patent/AR078160A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Los presentes derivados son utiles para tratar un trastorno que responde a la activacion de los canales Kv7. Reivindicacion 1: Un compuesto de formula (1) un estereoisomero o una mezcla de sus estereoisomeros, o una sal de adicion farmacéuticamente aceptable de dicho compuesto, o un N-oxido de dicho compuesto, en donde R1 y R2, junto con el nitrogeno al cual están unidos, forman un anillo heterocíclico seleccionado de pirrolidinilo, 2,5-dihidro-1H-pirrol-1-ilo, azetidinilo, tiazolidinilo, piperidinilo, piperazinilo y morfolinilo, donde dicho pirrolidinilo, azetidinilo, piperidinilo, piperazinilo y morfolinilo está opcionalmente sustituido una o varias veces con un sustituyente seleccionado del grupo que consiste en halo y trifluorometilo; R3 representa un anillo heterocíclico seleccionado de furanilo y pirrolilo, donde el furanilo y pirrolilo está opcionalmente sustituido una o varias veces con sustituyentes seleccionados de alquilo C1-6, alcoxi C1-6, halo y trifluorometilo; R4 representa alquilo C1-6; y R5 y R6, junto con el nitrogeno al cual están unidos, forman un anillo heterocíclico seleccionado de morfolinilo y 1,4-oxazepanilo.
ARP100103258A 2009-09-07 2010-09-06 Derivados de aminopiridina sustituidos, a su uso en terapia, y a composiciones farmaceuticas que los contiene AR078160A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200901001 2009-09-07

Publications (1)

Publication Number Publication Date
AR078160A1 true AR078160A1 (es) 2011-10-19

Family

ID=42813149

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100103258A AR078160A1 (es) 2009-09-07 2010-09-06 Derivados de aminopiridina sustituidos, a su uso en terapia, y a composiciones farmaceuticas que los contiene

Country Status (5)

Country Link
US (1) US20120238547A1 (es)
EP (1) EP2475656A1 (es)
AR (1) AR078160A1 (es)
TW (1) TW201114763A (es)
WO (1) WO2011026890A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2729176A1 (en) 2011-07-05 2014-05-14 Contera Pharma APS The use of serotonin receptor agonists for treatment of movement disorders
DK3160464T3 (en) 2014-06-26 2018-10-29 Contera Pharma Aps 6-hydroxybuspirone for use in the treatment of movement disorders
TW202521516A (zh) * 2023-08-17 2025-06-01 加拿大商再諾製藥公司 氮雜環庚烷及吡咯啶化合物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004080377A2 (en) 2003-03-11 2004-09-23 Neurosearch A/S Kcnq channel modulating compounds and their pharmaceutical use
EP1807407B1 (en) * 2004-10-22 2009-07-29 Janssen Pharmaceutica N.V. Aromatic amides as inhibitors of c-fms kinase
EP2298766B1 (en) 2005-03-03 2013-09-18 H. Lundbeck A/S Pharmaceutical formulations comrpising a substituted pyridine derivative
WO2010094645A1 (en) * 2009-02-17 2010-08-26 Neurosearch A/S Substituted pyridine derivatives and their medical use

Also Published As

Publication number Publication date
EP2475656A1 (en) 2012-07-18
TW201114763A (en) 2011-05-01
WO2011026890A1 (en) 2011-03-10
US20120238547A1 (en) 2012-09-20

Similar Documents

Publication Publication Date Title
PE20221910A1 (es) Derivados de pirazolilo utiles como agentes anticancerigenos
PE20221253A1 (es) Inhibidores de pequenas moleculas de mutante g12c de kras
AR068846A1 (es) Compuestos derivados de pirrolo (2,3d)-pirimidina inhibidores de la actividad de pkb, composiciones farmaceuticas que los contienen, proceso de preparacion y uso de los mismos como agentes anticancer
AR074876A1 (es) Derivados de indol-pirimidina para tratar cancer
AR077817A1 (es) Derivados de 1, 2, 4-triazol y su uso como pesticidas
AR081058A1 (es) Derivados de arilmetoxi isoindolina, composiciones que los comprenden y su uso en el tratamiento del cancer.
EA201000413A1 (ru) Способ получения производных лактамида, новые производные лактамида и препараты, содержащие производные лактамида
AR082638A1 (es) Derivados de tetrahidropiran utiles como pesticidas
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
AR070828A1 (es) Derivados de azetidina y ciclobutano como inhibidores de jak
MX343264B (es) Ciertas amino-piridazinas, composiciones de las mismas y metodos de uso de los mismos.
AR088175A1 (es) 3-pirimidin-4-il-oxazolidin-2-onas utiles para tratar cancer y composiciones farmaceuticas que las contienen
AR092269A1 (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
AR072906A1 (es) Nucleosidos modificados utiles como antivirales
AR090488A1 (es) Derivados de n-ciclobutilbenzamida, un proceso para su obtencion, intermediarios para su sintesis, composiciones pesticidas y farmaceuticas que los comprenden y metodos para controlar daños debidos a una plaga y/u hongos
AR074632A1 (es) Compuesto de amidofenoxiindazol, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util en el tratamiento de cancer
RU2016135922A (ru) Терапевтические соединения и композиции
AR081725A1 (es) Derivados de oxadiazol, proceso de preparacion de los mismos, composicion farmaceutica que los contienen y su uso en el tratamiento del cancer
IN2014DN07283A (es)
DOP2011000083A (es) Compuestos de amida utiles en terapia
AR087212A1 (es) ANTAGONISTAS DE CRTh2
PE20110213A1 (es) Derivados de indolinona como inhibidores de quinasa
AR057380A1 (es) Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
AR061111A1 (es) Derivados de isoindol utiles para tratar dolor,trastornos gastrointestinales y cancer
UY29234A1 (es) Derivados de adamantano, composiciones farmacéuticas que los contienen, procedimientos de preparación de ambos y aplicaciones.

Legal Events

Date Code Title Description
FB Suspension of granting procedure